位置:成果数据库 > 期刊 > 期刊详情页
白介素8的3种亚型对卵巢癌SKOV3细胞生物学活性的影响
  • ISSN号:1007-3639
  • 期刊名称:《中国癌症杂志》
  • 时间:0
  • 分类:R737.31[医药卫生—肿瘤;医药卫生—临床医学]
  • 作者机构:[1]广西医科大学肿瘤医院妇瘤科,广西区域高发肿瘤重点实验室,广西南宁530021
  • 相关基金:国家自然科学基金(No:30760266).
中文摘要:

背景与目的:卵巢癌的进展是一种多因素、多环节、多阶段的过程,近来研究表明卵巢癌患者白介素8(IL-8)水平显著高于良性肿瘤患者及健康人群,卵巢癌的生长和转移可能与过度表达的IL-8有关,但尚无报道表明IL-8主要亚型在卵巢癌中的作用。本研究探讨IL-8的3种亚型IL-8(1-77)、IL-8(5-77)和IL-8(9-77)对卵巢癌SKOV3细胞的增殖、生长、迁移和侵袭能力的影响及其作用机理。方法:确认分别获得IL-8的3种亚型稳定转染的SKOV3细胞后,应用MTT比色测定法比较各细胞的生长曲线;采用流式细胞仪比较各细胞的细胞生长周期;采用集落形成实验比较各组细胞的克隆率;运用Transwell小室比较各细胞体外迁移和侵袭能力。结果:IL-8(1-77)-pwpi-SKOV彝日胞和IL-8(5-77)-pwpi-SKOV3在G2期的比率明显高于SKOV3(P=0.017,P=0.020);IL-8(1-77)-pwpi-SKOV3和IL-8(5-77)-pwpi-SKOV3细胞克隆率明显高于SKOV3(P=0.000,P=0.001),IL-8(9-77)-pwpi-SKOV3细胞克隆率明显低于SKOV3(P=0.013);细胞体外迁移能力多组间差异无统计学意义(P〉0.05),但细胞体外侵袭能力IL-8(1-77)-pwpi-SKOV3和IL-8(5-77)-pwpi-SKOV3明显强于SKOV3(P=0.000,P=0.002),IL-8(9-77)-pwpi-SKOV3明显弱于SKOV3(P=0.067)。结论:IL-8(1-77)和IL-8(5-77)可能促进卵巢癌SKOV3细胞的生长和增殖,并增强其侵袭能力,而IL-8(9-77)对卵巢癌SKOV3细胞增殖可能有抑制作用。

英文摘要:

Background and purpose: Ovarian cancer progression is a multistep process. Recent research shows that IL-8 level of ovarian cancer patients is significantly higher than that of patients with benign tumors and normal people, the growth and metastasis of ovarian cancer may be associated with over-expression of IL-8, but there is no report about the function of the main subtypes of IL-8 in ovarian cancer. The study was to investigate the influence of IL-8 three subtypes on ovarian cancer SKOV3 cell proliferation, growth, migrating and invasive capability, and the underlying mechanism. Methods: After confirming obtaining SKOV3 cell with three hypotypes IL-8(1-77), IL-8(5-77), IL-8(9-77) over-expression respectively, MTT colorimetric method was used to detect the growth cure of different cells; The flow cytometry was used to compare the cell cycle of different cells; The cell proliferation capability of different cells was tested by the cell body colony formation; Transwell closet was used to compare different cell body's external migration and invasive capability. Results: IL-8(1-77)-pwpi-SKOV3 and IL-8(5-77)-pwpi-SKOV3 cells in the ratio of G2 phase were significantly higher than that of SKOV3 cells (P=0.017 and 0.020). The cloning formation rate of IL- 8(1-77)-pwpi-SKOV3 and IL-8 (5-77) -pwpi-SKOV3 cells were significantly higher than that of SKOV3 cells (P=0.000 and 0.001), IL-8 (9-77)-pwpi-SKOV3 cells was significantly lower than SKOV3 cells (P=0.013); the migration ability in vitro of different groups of cells had no statistically significant differences (P〉0.05), but the invasion ability invitro of IL-8( 1-77 )-pwpi-SKOV3 and IL-8 (5-77) -pwpi-SKOV3 cells were significantly stronger than that of SKOV3 cells(P=0.000 and 0.002), IL-8 (9-77) -pwpi-SKOV3 cells was significantly weaker than that of SKOV3 cells(P=0.067). Conclusion: The subtypes of IL-8 (1-77) and IL-8 (5-77) can promote ovarian cancer SKOV3 cell growth and prolif

同期刊论文项目
同项目期刊论文
期刊信息
  • 《中国癌症杂志》
  • 中国科技核心期刊
  • 主管单位:中华人民共和国教育部
  • 主办单位:复旦大学附属肿瘤医院
  • 主编:沈镇宙
  • 地址:上海市徐汇区东安路270号6号楼3楼
  • 邮编:200032
  • 邮箱:zgazzz@163.com
  • 电话:021-64188274 64175590-3574
  • 国际标准刊号:ISSN:1007-3639
  • 国内统一刊号:ISSN:31-1727/R
  • 邮发代号:4-575
  • 获奖情况:
  • 国内外数据库收录:
  • 被引量:19590